Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 21, 2005; 11(7): 1032-1036
Published online Feb 21, 2005. doi: 10.3748/wjg.v11.i7.1032
Table 4 Effect of tumor stage on the prevalence of H pylori (H pylori+) and CagA (CagA+) antibodies in 126 non-cardia gastric cancer patients.
Stage 1 (%) (n=31)Stage 2 (%) (n=10)Stage 3 (%) (n=30)Stage 4 (%) (n=55)
H pylori+80.67073.367.3
CagA+90.3809381.8
H pylori+ and/or CagA +96.89096.785.5